Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Vanuatu
Vanuatu: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 1.8% in 2024. ▬ Flat
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Vanuatu, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
In 2024, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Vanuatu stood at 1.8%. That is the highest value across all 10 years on record.
Compared with earlier readings it is up 5.9% on the previous year and up 5.9% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Vanuatu peaked at 1.8% in 2024 and was at its lowest, 1.5%, in 2019.
Vanuatu ranks 14th of 215 countries on this measure, in the top 10%.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Vanuatu, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.7% | — |
| 2016 | 1.7% | +0.0% |
| 2017 | 1.6% | -5.9% |
| 2018 | 1.6% | +0.0% |
| 2019 | 1.5% | -6.3% |
| 2020 | 1.5% | +0.0% |
| 2021 | 1.6% | +6.7% |
| 2022 | 1.7% | +6.2% |
| 2023 | 1.7% | +0.0% |
| 2024 | 1.8% | +5.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.6% | 1.5% | 1.7% | 5 |
| 2020s | 1.7% | 1.5% | 1.8% | 5 |
Countries ranked near Vanuatu
More development goals data for Vanuatu
- Red List Index 0.7273 (2025)
- Number of refugees per 100,000 population, by country of origin 5.07 (2025)
- Manufacturing value added per capita 70.05 (2025)
- Number of transboundary breeds 5 (2025)
- Number of transboundary breeds (not extinct) 5 (2025)
- Number of transboundary breeds with unknown risk status 5 (2025)
- Number of local breeds with unknown risk status 6 (2025)
- Number of local breeds (not extinct) 6 (2025)
- Number of local breeds kept in the country 6 (2025)
- Infant deaths 130 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Vanuatu?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Vanuatu was 1.8% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Vanuatu?
- The highest recorded value was 1.8% in 2024.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Vanuatu?
- The lowest recorded value was 1.5% in 2019.
- How does Vanuatu rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Vanuatu ranks 14th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Vanuatu?
- Over the last ten years it is up 5.9%. The long-run trend across the full record is flat.
- Where does this Vanuatu data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).